204 related articles for article (PubMed ID: 28648654)
1. Gianturco Z-Stent Fixation of a Modified Iliac Limb Stent-Graft Endoprosthesis for the Treatment of Malignant Superior Vena Cava Syndrome.
Chick JFB; Osher ML; Cooper KJ; Saad WE; Williams DM; Khaja MS
Ann Vasc Surg; 2017 Nov; 45():263.e1-263.e4. PubMed ID: 28648654
[TBL] [Abstract][Full Text] [Related]
2. Malignant obstruction of superior vena cava: Endovascular stenting using Y-configuration stent in stent technique.
Noor Khairiah AK; Mohamad Nazrulhisham MN; Hazman MN
Med J Malaysia; 2018 Dec; 73(6):407-409. PubMed ID: 30647215
[TBL] [Abstract][Full Text] [Related]
3. Malignant superior vena cava syndrome: a comparative cohort study of treatment with covered stents versus uncovered stents.
Gwon DI; Ko GY; Kim JH; Shin JH; Yoon HK; Sung KB
Radiology; 2013 Mar; 266(3):979-87. PubMed ID: 23249571
[TBL] [Abstract][Full Text] [Related]
4. Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava.
Nagata T; Makutani S; Uchida H; Kichikawa K; Maeda M; Yoshioka T; Anai H; Sakaguchi H; Yoshimura H
Cardiovasc Intervent Radiol; 2007; 30(5):959-67. PubMed ID: 17546400
[TBL] [Abstract][Full Text] [Related]
5. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
Geraghty PJ; Mewissen MW; Jaff MR; Ansel GM;
J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Malignant Superior Vena Cava Syndrome Using a Bifurcated Aortic Endograft.
Kahn SL; Kravetz AJ; Norris MA; Kaufman JL
J Vasc Interv Radiol; 2016 Nov; 27(11):1708-1710. PubMed ID: 27926389
[No Abstract] [Full Text] [Related]
7. Comparison of Covered Versus Uncovered Stents for Benign Superior Vena Cava (SVC) Obstruction.
Haddad MM; Simmons B; McPhail IR; Kalra M; Neisen MJ; Johnson MP; Stockland AH; Andrews JC; Misra S; Bjarnason H
Cardiovasc Intervent Radiol; 2018 May; 41(5):712-717. PubMed ID: 29492630
[TBL] [Abstract][Full Text] [Related]
8. Stent-graft in the management of superior vena cava syndrome.
Chin DH; Petersen BD; Timmermans H; Rösch J
Cardiovasc Intervent Radiol; 1996; 19(4):302-4. PubMed ID: 8755091
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous endovascular management of chronic superior vena cava syndrome of benign causes : long-term follow-up.
Breault S; Doenz F; Jouannic AM; Qanadli SD
Eur Radiol; 2017 Jan; 27(1):97-104. PubMed ID: 27085696
[TBL] [Abstract][Full Text] [Related]
10. Severe obstruction of the superior vena cava caused by tumor invasion. Recanalization using a PTFE-covered Z stent.
Dendo S; Inaba Y; Arai Y; Matsueda K; Aramaki T; Tanaka T; Furutani K; Fuwa N
J Cardiovasc Surg (Torino); 2002 Apr; 43(2):287-90. PubMed ID: 11887072
[TBL] [Abstract][Full Text] [Related]
11. Stenting for superior vena cava obstruction in pediatric heart transplant recipients.
Sachdeva R; Seib PM; Burns SA; Fontenot EE; Frazier EA
Catheter Cardiovasc Interv; 2007 Nov; 70(6):888-92. PubMed ID: 17932887
[TBL] [Abstract][Full Text] [Related]
12. Fast-track management of malignant superior vena cava syndrome.
Lee-Elliott CE; Abubacker MZ; Lopez AJ
Cardiovasc Intervent Radiol; 2004; 27(5):470-3. PubMed ID: 15383849
[TBL] [Abstract][Full Text] [Related]
13. Visceral stent patency in fenestrated stent grafting for abdominal aortic aneurysm repair.
Grimme FA; Zeebregts CJ; Verhoeven EL; Bekkema F; Reijnen MM; Tielliu IF
J Vasc Surg; 2014 Feb; 59(2):298-306. PubMed ID: 24080136
[TBL] [Abstract][Full Text] [Related]
14. Benign superior vena cava syndrome: stenting is now the first line of treatment.
Rizvi AZ; Kalra M; Bjarnason H; Bower TC; Schleck C; Gloviczki P
J Vasc Surg; 2008 Feb; 47(2):372-80. PubMed ID: 18241760
[TBL] [Abstract][Full Text] [Related]
15. Double Chimney Technique Using Interwoven Self-Expanding Nitinol Stents to Treat Recurrent Nonmalignant Thoracic Central Vein In-Stent Restenosis.
Chi WK; Tam G; Yan BP
Vasc Endovascular Surg; 2019 Feb; 53(2):147-149. PubMed ID: 30092723
[No Abstract] [Full Text] [Related]
16. Endovascular stent-based revascularization of malignant superior vena cava syndrome with concomitant implantation of a port device using a dual venous approach.
Anton S; Oechtering T; Stahlberg E; Jacob F; Kleemann M; Barkhausen J; Goltz JP
Support Care Cancer; 2018 Jun; 26(6):1881-1888. PubMed ID: 29274029
[TBL] [Abstract][Full Text] [Related]
17. [Effectiveness of endovascular prostheses as initial treatment for superior vena cava syndrome of malignant cause].
Talens A; Ferrer S; González-Cruz A; Blanco E; García-Ferrer L; Iranzo V; Camps C
Med Clin (Barc); 2013 Jan; 140(2):59-65. PubMed ID: 22237043
[TBL] [Abstract][Full Text] [Related]
18. Superior vena cava stent placement: results with the Wallstent endoprosthesis.
Hennequin LM; Fade O; Fays JG; Bic JF; Jaafar S; Bertal A; Anthoine D; Bernadac PA
Radiology; 1995 Aug; 196(2):353-61. PubMed ID: 7617844
[TBL] [Abstract][Full Text] [Related]
19. In situ fenestration of the internal iliac artery as a bailout technique associated with endovascular repair of an abdominal aortic aneurysm: long-term follow-up.
Wheatley GH
J Endovasc Ther; 2012 Dec; 19(6):716-20. PubMed ID: 23210866
[TBL] [Abstract][Full Text] [Related]
20. A new nitinol stent for use in superior vena cava syndrome. Initial clinical experience.
Andersen PE; Midtgaard A; Brenøe AS; Elle B; Duvnjak S
J Cardiovasc Surg (Torino); 2015 Dec; 56(6):877-81. PubMed ID: 26212865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
